JD Health International Inc. (JDHIF) Research

JD Health International Inc., an investment holding firm, operates a prominent online healthcare platform within the People's Republic of China. The company distributes a wide array of pharmaceutical and wellness products, encompassing both over-the-counter and prescription medications, alongside medical equipment, supplies, nutritional supplements, and restorative tonics. These are made available via both direct sales channels and an extensive online retail pharmacy network. Beyond products, it furnishes a comprehensive suite of digital healthcare services, including virtual consultations, facilitating referrals to hospitals or specialists, health assessments, genetic screening, and aesthetic treatments. Additionally, the platform delivers sophisticated health management solutions and intelligent healthcare technologies, complemented by technical assistance and advertising services. Users can also access specialized offerings such as preventive health check-ups, cosmetic procedures, vaccination scheduling, dental care, and nucleic acid testing. Established in 2018, the company maintains its headquarters in Beijing, PRC, and operates as a subsidiary of JD Jiankang Limited.

Open JD Health International Inc. (JDHIF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.